IP Library Granted Patent US 9,534,977
Granted Patent B2
US 9,534,977 · App. 14/830,547 · Granted Jan 3, 2017

Intraluminal pressure detection for diverticular disease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,534,977
App. No.
14/830,547
Granted
Jan 3, 2017
Kind
B2
Abstract

A pressure detection tablet is disclosed. The tablet is a capsule including a dye encapsulated within an inner coating, in which the inner coating is configured to rupture at a pressure equal to or greater than a pressure threshold. The tablet further includes an outer coating surrounding the capsule, in which the outer coating is configured to provide delivery of the capsule to a targeted site. The dye may be a non-metabolized, water soluble dye, such that a ruptured capsule releases the dye which can be visually detected in the urine. In some embodiments, the disclosure provides a method of making the tablet, using the tablet to detect peak pressure in the colon and reducing the risk of developing a colonic disorder.

Claims (12)

1. A pressure detection tablet, comprising:

a capsule comprising a dye encapsulated within an inner coating, wherein the inner coating is configured to rupture at a pressure equal to or greater than a pressure threshold; and

an outer coating surrounding the capsule, wherein the outer coating is configured to provide delivery of the capsule to a targeted site such as the colon.

2. The pressure detection tablet of claim 1 , wherein the dye is water-soluble and non-metabolizable.

3. The pressure detection tablet of claim 1 , wherein the inner coating comprises a pressure-sensitive polymer.

4. The pressure detection tablet of claim 1 , wherein the pressure threshold of the inner coating is selectable based on variations in a thickness, density, elasticity or a combination thereof of the inner coating.

5. The pressure detection tablet of claim 1 , wherein the outer coating comprises a pH sensitive polymer that is insoluble at the acidic pH of the stomach and proximal small intestine.

6. The pressure detection tablet of claim 5 , wherein the pH sensitive polymer for the outer coating is selected from the group consisting of methacrylic acid ester, shellec, and hydroxylpropylmethylcellulose acetate succinate.

7. The pressure detection tablet of claim 5 , wherein the pH sensitive polymer for the outer coating comprises a copolymer of EUDRAGIT L and EUDRAGIT S polymers, formulated to dissolve at neutral pH.

8. The pressure detection tablet of claim 5 , wherein the outer coating further comprises azo polymers of styrene and 2-hydroxy methyl acrylate, formulated to dissolve by bacterial degradation.

9. The pressure detection tablet of claim 1 , wherein the tablet comprises at least two capsules surrounded by the outer coating.

10. The pressure detection tablet of claim 9 , wherein the at least two capsules comprise different dyes and are configured to rupture at equal to or higher than a different pressure threshold from one another.

Assignments (3)
SECURITY INTEREST Recorded Jan 29, 2019
From: EMPIRE TECHNOLOGY DEVELOPMENT LLC
To: CRESTLINE DIRECT FINANCE, L.P.
Reel/Frame 048373/0217 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2016
From: MISHRA, HIMANSHU; SHARMA, MONA; DIXIT, MANDAR SHIRISH
To: CURIOUS INK DESIGN CONSULTING
Reel/Frame 039577/0014 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2016
From: CURIOUS INK DESIGN CONSULTING
To: EMPIRE TECHNOLOGY DEVELOPMENT LLC
Reel/Frame 039577/0068 →